13th Annual World Clinical Biomarkers & CDx Summit

Visit us at booth E30 to learn how we can partner for end-to-end support of your research and development program.

We help you analyze more data in more depth, so you can produce more effective therapies. Attending the 13th Annual World Clinical Biomarkers & CDx Summit? Schedule a meeting with our team to discuss our:

  • AI-powered digital pathology solutions
  • Immuno-oncology biomarker development and validation
  • Spatial biology and molecular diagnostics analysis
  • Immunotherapy clinical trial support
  • CDx development
  • Regulatory guidance
Tom Turi, Ph.D.

Tom Turi, Ph.D.

Chief Scientific Officer at Flagship Biosciences

Friday, September 8 at 12:30 pm

Enabling Precision Medicine Through Digital Pathology

  1. Expanding the repertoire of biomarkers for patient stratification
  2. Implementing digital pathology as an integral component of clinical trials
  3. Validation of digital pathology solutions

Join Flagship CSO, Tom Turi, and other industry experts at the 13th Annual World Clinical Biomarkers & CDx Summit to address critical challenges and discover insights. Across 2 days, 50+ world-class industry stakeholders will address the most critical challenges in Biomarker Discovery & Translational Development, Clinical Biomarker Development, and CDx Development & Commercialization.

Interested in Partnering with Us?

Validated Assays for Use in Immunotherapy Research & Development.

  • Customizable options optimized to your needs and validation requirements
  • Ability to create multiplex assays to characterize complex cellular interactions

Tailored Companion Diagnostics solutions to meet your research needs

  • Valuable insights that can inform clinical decisions and support drug development programs
  • Expertise in developing assays for oncology, immune-oncology, neuromuscular disorders, and cell & gene therapies for rare diseases
  • Preliminary research, tissue biomarker assay optimization, and assay validation

Tissue-Based Pathology Companion Diagnostic Development for Regulated Applications

  • Expertise in novel biomarker and tissue analyses
  • Regulatory strategy and support
  • Consult with scientific experts

Driving Your Biomarker Strategy: Facts by numbers

  • View our resume and history to learn why Flagship is the premier partner for your study
  • See the full list of spatial biology services that empower confident clinical decision making
  • See the benefits with a fully integrated team of scientists and pathologists

Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.

Recent Posts

2nd Annual Spatial Biology for Drug Development Summit

Meet us at the 2nd annual Spatial Biology for Drug Development Summit. We’re excited to be a Program Partner for the Spatial Biology for Drug Development Summit, returning to Boston for a 2nd year, October 22-24. This year, we’ll dive into the latest in spatial omics...

Spatial Biology East Coast US 2024

Meet with us at booth #25. As a Gold Sponsor for the third annual Spatial Biology East Coast Congress in Boston, we hope you’ll join our experts and over 350 other industry leaders to discuss the transforming field of spatial biology. Examine how spatial biology can...

2024 Annual Meeting

Meet with us at booth #37085. We help you analyze more data in more depth, so you can produce more effective therapies. Attending the 2024 ASCO® Annual Meeting? Schedule a meeting with our team to discuss our: AI-powered digital pathology solutions Biomarker...

2024 ASGCT Annual Meeting

Are you attending the 2024 ASGCT Annual Meeting? With field-leading keynotes, 200+ scientific sessions, over 7,000 researchers in attendance, and an expanded exhibit hall, the 27th American Society of Gene and Cell Therapy Annual Meeting is the nexus for gene and cell...